Apolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure

Apolipoprotein L1 gene (APOL1) nephropathy variants in African American deceased kidney donors were associated with shorter renal allograft survival in a prior single‐center report. APOL1 G1 and G2 variants were genotyped in newly accrued DNA samples from African American deceased donors of kidneys recovered and/or transplanted in Alabama and North Carolina. APOL1 genotypes and allograft outcomes in subsequent transplants from 55 U.S. centers were linked, adjusting for age, sex and race/ethnicity of recipients, HLA match, cold ischemia time, panel reactive antibody levels, and donor type. For 221 transplantations from kidneys recovered in Alabama, there was a statistical trend toward shorter allograft survival in recipients of two‐APOL1‐nephropathy‐variant kidneys (hazard ratio [HR] 2.71; p = 0.06). For all 675 kidneys transplanted from donors at both centers, APOL1 genotype (HR 2.26; p = 0.001) and African American recipient race/ethnicity (HR 1.60; p = 0.03) were associated with allograft failure. Kidneys from African American deceased donors with two APOL1 nephropathy variants reproducibly associate with higher risk for allograft failure after transplantation. These findings warrant consideration of rapidly genotyping deceased African American kidney donors for APOL1 risk variants at organ recovery and incorporation of results into allocation and informed‐consent processes.

[1]  R. Wolfe,et al.  Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. , 2004, The New England journal of medicine.

[2]  A. Garg,et al.  Living Kidney Donors Requiring Transplantation: Focus on African Americans , 2007, Transplantation.

[3]  C. Young,et al.  Living Donor Nephrectomy: Understanding Long‐Term Risk in Minority Populations , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[5]  A. Kirk,et al.  Effect of Donor Factors on Early Graft Survival in Adult Cadaveric Renal Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  John D Reveille,et al.  End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 , 2014, Arthritis & rheumatology.

[7]  K. Johansen,et al.  Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. , 2004, Journal of the American Society of Nephrology : JASN.

[8]  G. Genovese,et al.  The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5‐Year Allograft Survival , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  B. Vanhollebeke,et al.  The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill , 2010, Molecular microbiology.

[10]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[11]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .

[12]  A. Ashley-Koch,et al.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British journal of haematology.

[13]  Nicholette D. Palmer,et al.  Gene-gene interactions in APOL1-associated nephropathy. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  G. Genovese,et al.  APOL1 variants and kidney disease in people of recent African ancestry , 2013, Nature Reviews Nephrology.

[15]  T. Oyetunji,et al.  Effect of donor ethnicity on kidney survival in different recipient pairs: an analysis of the OPTN/UNOS database. , 2009, Transplantation proceedings.

[16]  C. Winkler,et al.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.

[17]  M. Beggs,et al.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. , 2013, Journal of the American Society of Nephrology : JASN.

[18]  R. Steiner.  ‘Normal for Now’ or ‘At Future Risk’: A Double Standard for Selecting Young and Older Living Kidney Donors , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  J. Sedor,et al.  Translating associations between common kidney diseases and genetic variation into the clinic. , 2010, Seminars in nephrology.

[20]  Barry I. Freedman,et al.  APOL1 risk variants, race, and progression of chronic kidney disease. , 2013, The New England journal of medicine.

[21]  A. Garg,et al.  Consistency of Racial Variation in Medical Outcomes Among Publicly and Privately Insured Living Kidney Donors , 2014, Transplantation.

[22]  A. Israni,et al.  Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. , 2013, Transplantation reviews.

[23]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[24]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[25]  F. Port,et al.  Effect of waiting time on renal transplant outcome. , 2000, Kidney international.

[26]  D. Gjertson,et al.  Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. , 1992, The New England journal of medicine.

[27]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  J. Kopp.  JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction? , 2013, Kidney international.

[29]  T. Nickolas,et al.  Kidneys at Higher Risk of Discard: Expanding the Role of Dual Kidney Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  M. Rocco,et al.  JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.

[31]  Bertram L Kasiske,et al.  New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. , 2014, Journal of the American Society of Nephrology : JASN.

[32]  M. Schnitzler,et al.  Racial variation in medical outcomes among living kidney donors. , 2010, The New England journal of medicine.

[33]  A. Israni,et al.  The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. , 2014, American Society of Nephrology. Clinical Journal.

[34]  C. Young,et al.  African American living-kidney donors should be screened for APOL1 risk alleles. , 2011, Transplantation.

[35]  O. Gribouval,et al.  APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[37]  M. Rocco,et al.  The APOL1 Gene and Allograft Survival after Kidney Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  D.,et al.  Regression Models and Life-Tables , 2022 .

[39]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[40]  D. Slakey,et al.  The Contribution of Donor Quality to Differential Graft Survival in African American and Caucasian Renal Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.